Published in Antimicrob Agents Chemother on October 01, 1978
'1001' Campylobacters: cultural characteristics of intestinal campylobacters from man and animals. J Hyg (Lond) (1980) 6.72
A selective medium for isolating Campylobacter jejuni/coli. J Clin Pathol (1982) 5.59
Campylobacter enteritis. Can Med Assoc J (1979) 5.14
Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother (1981) 3.05
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother (1985) 2.85
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Antimicrob Agents Chemother (1980) 2.38
Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Antimicrob Agents Chemother (1979) 2.29
Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother (1988) 2.26
Evaluation of media for isolation of Campylobacter fetus subsp. jejuni from fecal specimens. J Clin Microbiol (1981) 2.04
Susceptibility testing of Campylobacter fetus subsp. jejuni, using broth microdilution panels. Antimicrob Agents Chemother (1982) 1.88
In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother (1985) 1.88
Comparison of selective media for primary isolation of Campylobacter fetus subsp. jejuni. J Clin Microbiol (1981) 1.75
Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother (1994) 1.69
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother (1991) 1.67
Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media. J Clin Microbiol (1985) 1.65
Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother (1983) 1.53
Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents. Antimicrob Agents Chemother (1981) 1.38
Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility. Antimicrob Agents Chemother (1989) 1.29
In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam. Antimicrob Agents Chemother (1985) 1.29
Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates. Antimicrob Agents Chemother (1987) 1.27
Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother (1985) 1.25
In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs. Antimicrob Agents Chemother (1985) 1.17
Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods. J Clin Microbiol (1983) 1.16
Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics. Antimicrob Agents Chemother (1987) 1.12
Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1991) 1.12
Isolation and characterization of cephalothin-susceptible Campylobacter coli from slaughter cattle. J Clin Microbiol (1986) 1.10
In vitro antimicrobial susceptibility, plasmid analysis, and serotyping of epidemic-associated Campylobacter jejuni. J Clin Microbiol (1985) 1.09
Neonatal campylobacter enteritis. Can Med Assoc J (1980) 1.01
Early treatment of Campylobacter jejuni enteritis. Antimicrob Agents Chemother (1989) 1.00
In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin. Antimicrob Agents Chemother (1991) 0.91
In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole. Antimicrob Agents Chemother (1984) 0.84
Campylobacter enteritis in the community. Br Med J (Clin Res Ed) (1983) 0.81
[Campylobacteriosis in humans caused by subspecies intestinalis and fetus. Six new diseases (author's transl)]. Infection (1982) 0.77
In vitro susceptibility of Campylobacter jejuni to rokitamycin. Antimicrob Agents Chemother (1990) 0.75
Campylobacter jejuni peritonitis complicating continuous ambulatory peritoneal dialysis. J Clin Microbiol (1982) 0.75
Campylobacter colitis--a cause of chronic diarrhea in children. West J Med (1982) 0.75
Erythromycin-resistant Campylobacter jejuni. Can Med Assoc J (1980) 0.75
Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77
Related vibrio in stools. J Pediatr (1973) 12.85
Acute enteritis due to related vibrio: first positive stool cultures. J Infect Dis (1972) 9.82
Human infections with Vibrio fetus and a closely related vibrio. J Infect Dis (1958) 8.30
Campylobacter enteritis in Brussels. Lancet (1978) 6.37
Vibrionic enteritis in infants. Am J Dis Child (1961) 5.82
Enteritis due to "related vibrio" in children. Am J Dis Child (1973) 5.04
Case of human vibriosis. Br Med J (1967) 4.97
Human vibriosis: indigenous cases in England. Br Med J (1967) 4.34
Letter: Related vibrios in Africa. Lancet (1973) 2.76
Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother (1974) 2.41
Infection due to a "related" Vibrio. J Pediatr (1961) 1.54
ANTIBIOTIC SENSITIVITY OF PHYSIOLOGIC GROUPS OF MICROAEROPHILIC VIBRIOS. Am J Vet Res (1964) 1.44
[Digestive origin of Campylobacter septicemias]. Nouv Presse Med (1977) 1.37
Campylobacter enteritis. Clin Gastroenterol (1979) 18.67
Related vibrio in stools. J Pediatr (1973) 12.85
Acute enteritis due to related vibrio: first positive stool cultures. J Infect Dis (1972) 9.82
Campylobacter enteritis in Brussels. Lancet (1978) 6.37
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
Enteritis due to "related vibrio" in children. Am J Dis Child (1973) 5.04
Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique. J Antimicrob Chemother (1982) 3.52
Campylobacter serotyping a epidemiology. Lancet (1981) 3.18
Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet (1985) 2.84
Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis (2002) 2.84
Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol (1998) 2.80
Letter: Related vibrios in Africa. Lancet (1973) 2.76
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol (2001) 2.62
Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.45
Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics. Antimicrob Agents Chemother (1974) 2.41
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol (1991) 2.26
Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol (1986) 2.25
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob Agents Chemother (1986) 2.12
Outbreak of recurrent abdominal cramps associated with Arcobacter butzleri in an Italian school. J Clin Microbiol (1992) 2.11
Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05
Campylobacter upsaliensis enteritis associated with canine infections. Lancet (1991) 2.05
A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol (1983) 2.03
Genotypic and phenotypic methods for the investigation of a nosocomial Legionella pneumophila outbreak and efficacy of control measures. J Infect Dis (1992) 1.97
Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91
Routine culture of Giardia lamblia trophozoites from human duodenal aspirates. Lancet (1984) 1.86
Detection of beta-glucuronidase in lactose-fermenting members of the family Enterobacteriaceae and its presence in bacterial urine cultures. J Clin Microbiol (1984) 1.78
Community-acquired bacteremia among hospitalized children in rural central Africa. Int J Infect Dis (2001) 1.76
Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol (1995) 1.72
Acidification of methyl-alpha-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis. J Clin Microbiol (1996) 1.72
Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother (1994) 1.66
Gas-liquid chromatography as screening test for Clostridium difficile. Lancet (1981) 1.63
Serotyping of Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis from domestic and wild animals. Appl Environ Microbiol (1985) 1.62
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59
Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J Clin Microbiol (1988) 1.54
Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Antimicrob Agents Chemother (1982) 1.52
Characterization of the 6'-N-aminoglycoside acetyltransferase gene aac(6')-Im [corrected] associated with a sulI-type integron. Antimicrob Agents Chemother (1997) 1.51
Flavobacterium multivorum septicemia in a hemodialyzed patient. J Clin Microbiol (1984) 1.49
In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob Agents Chemother (1988) 1.47
Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus. Genitourin Med (1988) 1.45
Contribution of the 13C-urea breath test to the detection of Helicobacter pylori gastritis in children. Pediatrics (1992) 1.41
Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J Clin Microbiol (1992) 1.38
[Digestive origin of Campylobacter septicemias]. Nouv Presse Med (1977) 1.37
Enteropathogenic agents in children with diarrhoea in rural Zaire. Lancet (1983) 1.35
Is "Campylobacter upsaliensis" an unrecognised cause of human diarrhoea? Lancet (1990) 1.32
Speed of bactericidal action of penicillin G, ampicillin, and carbenicillin on Bacteroides fragilis. Antimicrob Agents Chemother (1974) 1.31
Failure of live, attenuated oral rotavirus vaccine. Lancet (1986) 1.30
External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol (2005) 1.29
In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda. Genitourin Med (1986) 1.29
Campylobacter pyloridis in children. Lancet (1986) 1.28
Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin. Lancet (1991) 1.28
Semisolid selective-motility enrichment medium for isolation of salmonellae from fecal specimens. J Clin Microbiol (1984) 1.23
Ehrlichiosis in Belgium. Lancet (1995) 1.22
In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985. Antimicrob Agents Chemother (1990) 1.21
Campylobacter jejuni post-transfusional septicaemia. Lancet (1979) 1.20
Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin Belg (1996) 1.20
Stomatitis with septicemia due to Moraxella osloensis. J Pediatr (1974) 1.20
Effect of antibiotics carry-over on bacterial counting by 'spiral plating'. J Antimicrob Chemother (1988) 1.19
Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol (1998) 1.19
Semisolid blood-free selective-motility medium for the isolation of campylobacters from stool specimens. J Clin Microbiol (1989) 1.18
Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.16
Isolation of Campylobacter concisus from feces of children with and without diarrhea. J Clin Microbiol (1996) 1.15
Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. J Clin Microbiol (1988) 1.15
Results of screening for verocytotoxin-producing Escherichia coli in faeces in Belgium. Eur J Clin Microbiol Infect Dis (1990) 1.13
Comparative inhibitory activity of BL-S640 and two other cephalosporins. J Antibiot (Tokyo) (1975) 1.11
Isolation of Mobiluncus in four cases of extragenital infections in adult women. Eur J Clin Microbiol (1984) 1.10
A sentinel network of microbiological laboratories as a tool for surveillance of infectious diseases in Belgium. Epidemiol Infect (1991) 1.08
New selective medium for isolation of Campylobacter jejuni from faecal specimens. Lancet (1983) 1.08
Paediatric campylobacter diarrhoea from household exposure to live chickens in Lima, Peru. Bull World Health Organ (1988) 1.08
Chronic Ureaplasma urealyticum amnionitis associated with abruptio placentae. Obstet Gynecol (1986) 1.07
Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol (1984) 1.07
Campylobacter enteritis. Acta Paediatr Belg (1979) 1.06
Disk sensitivity testing for Campylobacter jejuni. Eur J Clin Microbiol (1984) 1.06
[Effects of sodium chloride on the antistaphylococcal action of gentamicin]. Pathol Biol (Paris) (1972) 1.06
Evaluation of a new method for routine in vitro cultivation of Giardia lamblia from human duodenal fluid. J Clin Microbiol (1985) 1.06
Isolation of Bacteroides corrodens and Eikenella corrodens from human clinical specimens. Comparative study of incidence and methods of identification. Infection (1977) 1.06
Cross-reactivity of environmental bacteria with fluorescent-antibody conjugates for Legionella pneumophila. Eur J Clin Microbiol (1984) 1.06
Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children. Pediatr Infect Dis J (2001) 1.06
Antagonism limit of penicillin G and chloramphenicol against Neisseria meningitidis. Arzneimittelforschung (1971) 1.06
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections. Antimicrob Agents Chemother (1982) 1.05
Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis (1995) 1.05
Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol (1987) 1.05
In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents. Antimicrob Agents Chemother (1985) 1.05
Yersinia pseudotuberculosis septicaemia in thalassaemia major. Lancet (1984) 1.04
Comparative in vitro acitvity of chloramphenicol and thiamphenicol on common aerobic and anaerobic gram-negative bacilli(Salmonella and Shigella excluded). Chemotherapy (1975) 1.04
Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms. Antimicrob Agents Chemother (1983) 1.04